Core Laboratories (NYSE:CLB – Get Free Report) issued its quarterly earnings results on Wednesday. The oil and gas company reported $0.23 EPS for the quarter, hitting analysts’ consensus estimates of $0.23, Zacks reports. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. Core Laboratories updated its Q1 2025 guidance to 0.120-0.160 EPS.
Core Laboratories Trading Down 2.6 %
Shares of CLB opened at $18.06 on Thursday. The stock has a fifty day moving average price of $19.00 and a two-hundred day moving average price of $19.49. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48. The company has a market cap of $847.73 million, a price-to-earnings ratio of 28.15, a PEG ratio of 1.14 and a beta of 2.39. Core Laboratories has a 52-week low of $13.82 and a 52-week high of $25.13.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Citigroup reduced their target price on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a research note on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. According to data from MarketBeat, Core Laboratories presently has a consensus rating of “Hold” and an average target price of $17.00.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Further Reading
- Five stocks we like better than Core Laboratories
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- What Are Dividend Achievers? An Introduction
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
- Business Services Stocks Investing
- Royal Caribbean Soars, But Smooth Sailing Isn’t Guaranteed
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
